Cardiac Myocytes Activated by Septic Plasma Promote Neutrophil Transendothelial Migration: Role of Platelet-Activating Factor and the Chemokines LIX and KC

Circulation Research

Volumn 94, Issue 7, 2004, Pages 944-951

  Madorin, W Sean ^a   Rui, Tao ^a   Sugimoto, Naohito ^a   Handa, Osamu ^a   Cepinskas, Gediminas ^a   Kvietys, Peter R ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Interleukin 1 ; Mice; Nuclear factor B; Tumor necrosis factor

Indexed keywords

ALPHA CHEMOKINE; APAFANT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1BETA; KC CHEMOKINE; LIX CHEMOKINE; MONOCLONAL ANTIBODY; PROTEASOME INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL LEVEL; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENDOTHELIUM CELL; HEART MUSCLE CELL; MONOLAYER CULTURE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONITIS; PLASMA; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SEPSIS; TRANSCYTOSIS;

ANIMALS; ANIMALS, NEWBORN; AZEPINES; CECUM; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; INTESTINAL PERFORATION; LEUPEPTINS; LIGATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIENZYME COMPLEXES; MYOCYTES, CARDIAC; NEUTROPHILS; NF-KAPPA B; PERITONITIS; PLASMA; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; SEPSIS; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842863228     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000124395.20249.AE     Document Type: Article

References (49)

1. Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation. 2000;7:83-101.
2. Neviere RR, Cepinskas G, Madorin WS, Hoque N, Karmazyn M, Sibbald WJ, Kvietys PR. LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes. Am J Physiol. 1999;277:H885-H892.
3. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol. 1991;261:G1051-G1056.
4. Tateda K, Moore TA, Newstead MW, Tsai WC, Zeng X, Deng JC, Chen G, Reddy R, Yamaguchi K, Standiford TJ. Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun. 2001;69:2017-2024.
5. Blackwell TS, Yull FE, Chen C-L, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD. Multiorgan nuclear factor κB activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med. 2000;162:1095-1101.
6. Lush CW, Cepinskas G, Kvietys PR. LPS tolerance in human endothelial cells; reduced PMN adhesion, E-selectin expression and NF-κB mobilization. Am J Physiol. 2000;278:H853-H861.
7. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 1994;12:141-179.
8. Read MA, Whitley MZ, Williams AJ, Collins T. NFκB and IκBα: an inducible regulatory system in endothelial activation. J Exp Med. 1994;179:503-512.
9. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 1999;18:6853-6866.
10. Smith JB, Herschman HR. Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine. J Biol Chem. 1995;270:16756-16765.
11. Chandrasekar B, Smith JB, Freeswick PD. Ischemia-reperfusion of rat myocardium activates nuclear factor-κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation. 2001;103:2296-2302.
12. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg. 1997;84:920-935.
13. Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock. Crit Care Clin. 2000;16:251-287.
14. Kumar A, Thota V, Dee L, Olson J, Parrillo JE. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183:949-958.
15. Fernandes Junior CJ, Iervolino M, Neves RA, Sampaio EL, Knobel E. Interstitial myocarditis in sepsis. Am J Cardiol. 1994;74:958.
16. Madorin WS, Cepinskas G, Kvietys PR. Peritonitis induces rat cardiac myocytes to promote polymorphonuclear leukocyte emigration and activate endothelial cells: effect of lipopolysaccharide pretreatment. Crit Care Med. 2001;29:1774-1779.
17. Reinhardt PH, Ward CA, Giles WR, Kubes P. Emigrated rat neutrophils adhere to cardiac myocytes via α4 integrin. Circ Res. 1997;81:196-201.
18. Poon BY, Ward CA, Giles WR, Kubes P. Emigrated neutrophils regulate ventricular contractility via α4 integrin. Circ Res. 1999;84:1245-1251.
19. Entman ML, Youker KA, Shappell SB, Siegel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW. Neutrophil adherence to isolated adult canine myocytes: evidence for a CD18-dependent mechanism. J Clin Invest. 1990;85:1497-1506.
20. Smith CW, Entman ML, Lane CL, Beaudet AL, Ty TI, Youker KA, Hawkins HK, Anderson DC. Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. J Clin Invest. 1991;88:1216-1223.
21. Youker KA, Smith CW, Anderson DC, Miller D, Michael LH, Rossen RD, Entman ML. Neutrophil adherence to isolated adult cardiac myocytes: induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest. 1992;89:602-609.
22. Kacimi R, Karliner JS, Koudssi F, Long CS. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ Res. 1998;82:576-586.
23. Rui T, Cepinskas G, Feng Q, Ho YS, Kvietys PR. Cardiac myocytes exposed to anoxia-reoxygenation promote neutrophil transendothelial migration. Am J Physiol Heart Circ Physiol. 2001;281:H440-H447.
24. Lush CW, Cepinskas G, Sibbald WJ, Kvietys PR. Endothelial E- and P-selectin expression in iNOS-deficient mice exposed to polymicrobial sepsis. Am J Physiol. 2001;280:G291-G297.
25. Cepinskas G, Noseworthy R, Kvietys PR. Transendothelial neutrophil migration: role of neutrophil-derived proteases and relationship to transendothelial protein movement. Circ Res. 1997;81:618-626.
26. Granger DN, Kvietys PR, Korthuis RJ. Microcirculation of the intestinal mucosa. In: Wood JD, ed. Handbook of Physiology, Section 6: The Gastrointestinal System Vol 1: Motility and Circulation, Part II. Baltimore, Md: Waverly Press; 1989:975-986.
27. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun. 1996;64:4733-4738.
28. Ebong SJ, Call DR, Nemzek J, Bolgos G, Newcomb D, Remick DG. Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun. 1999;67:6603-6610.
29. Remick DG, Newcomb DE, Bolgos G, Call DR. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock. 2000;13:110-116.
30. Ebong SJ, Goyert SM, Nemzek J, Kim J, Bolgos G, Remick DG. Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality. Infect Immun. 2001;69:2099-2106.
31. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol. 1994;10:405-455.
32. Rovai LE, Herschman HR, Smith JB. The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol. 1998;64:494-502.
33. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274:R577-R595.
34. Oral H, Dorn GW, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem. 1997;272:4836-4842.
35. Kumar A, Krieger A, Symeoneides S, Kumar A, Parrillo JE. Myocardial dysfunction in septic shock, part II: role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth. 2001;15:485-511.
36. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH. Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function. Crit Care Med. 1999;27:1309-1308.
37. Remick DG, Call DR, Ebong SJ, Newcomb D, Nybom P, Nemzek J, Bolgos G. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Crit Care Med. 2001;29:473-481.
38. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture of endotoxemia. J Immunol. 1992;148:2724-2730.
39. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock. 1995;4:89-95.
40. Silverman N, Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001;15:2321-2342.
41. Abraham E. NF-κB activation. Crit Care Med. 2000;28:N100-N104.
42. Zhang XW, Liu Q, Wang, Thorlacius H. CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol. 2001;133:413-421.
43. Proost P, Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells: in vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol. 1993;150:1000-1010.
44. Rovai LE, Herschman HR, Smith JB. Cloning and characterization of the human granulocyte chemotactic protein-2 gene. J Immunol. 1997;158:5257-5266.
45. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med. 1991;74:1355-1362.
46. Smith JB, Rovai LE, Herschman HR. Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines. J Leukoc Biol. 1997;62:598-603.
47. Prescott SM, McIntyre TM, Zimmerman GA. Platelet activating factor: a phospholipid mediator of inflammation. In: Gallin JI, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:387-396.
48. Strieter RM, Kunkel SL, Keane MP, Standiford TJ. Chemokines in lung injury. Chest. 1999;116:103S-110S.
49. Bozic CR, Kolakowski LF, Gerard NP, Garcia-Rodriguez C, Uexkull-Guldenband C, Conklyn MJ, Breslow R, Showell HJ, Gerard C. Expression and biologic characterization of the murine chemokine KC. J Immunol. 1995;154:6048-6057.